Significant growth in market share and patients in Denmark
STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENO Fresh market data from the Danish Health Data Authority reveal that medical cannabis oil products in the Pilot Programme offered by Stenocare are steadily capturing market share with a growth of 90% during the last six quarters. Stenocare offers the only two oil products approved for sales in the Pilot for Danish patients, and it is expected that this trend will grow further when Stenocare’s third product is approved. This is expected within 4-6 months.Oil products for patients: Stenocare’s pharmaceutical approach